Table 8.
Outcomes based on kidney involvement, age of involvement and treatment
| Group | Patient group description | Age at 1st sign of SPLIS median (IQR) |
Age at last report median (IQR) |
Patient survival |
|---|---|---|---|---|
| 1 |
Non-kidney disease + Transplanted KD |
1.0 (1.8) Group 1 vs. Group 2 p = 0.0503 |
8 (11.5) Group 1 vs. Group 2 p = 0.0001 |
15 of 17 (88%) |
| 2 |
All KD Except Transplanted |
0.45 (2.7) | 1.38 (5.6) | 20 of 48 (42%) |
| 3 |
KD onset < 1y Except Transplanted |
0.11 (0.25) Group 3 vs. Group 4 p < 0.0001 |
0.38 (0.8) Group 3 vs. Group 4 p < 0.0001 |
7 of 30 (23%) |
| 4 |
KD onset ≥ 1y Except Transplanted) |
3.0 (3.4) | 6.5 (4.6) | 13 of 18 (72%) |
| 5 | KD onset ≥ 1y + non-kidney disease + Transplanted KD |
2.0 (4.0) Group 3 vs. Group 5 p < 0.0001 |
7 (4.6) Group 3 vs. Group 5 p < 0.0001 |
28 of 35 (80%) |